Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 July 2023 | Story Andre Damons | Photo Samkelo Fetile
Prof Catherine Comiskey
Prof Catherine Comiskey, a professor in Healthcare Statistics from the School of Nursing and Midwifery at Trinity College Dublin and Academic Director of CHARM-EU, presents a lecture on building a research career with global impact to members of the UFS Transformation of the Professoriate Mentoring Programme.

A visiting scholar from Trinity College Dublin in Ireland visited the University of the Free State (UFS) to work with staff members from the UFS Transformation of the Professoriate Mentoring Programme on identifying collaborations, writing, and building a research career.

Prof Catherine Comiskey, a professor in Healthcare Statistics from the School of Nursing and Midwifery at Trinity College Dublin and Academic Director of CHARM-EU – an EU-funded academic programme – held a writing retreat for participants in the Transformation of the Professoriate Mentoring Programme in the last week of June. She also worked with individual members to identify potential European and UK collaborators on various research projects. On Friday 30 June, she presented a lecture on building a research career with global impact.

Encouraging staff members

According to Dr Henriëtte van den Berg, Manager: Transformation of the Professoriate Mentoring Programme, Prof Comiskey encouraged colleagues to develop a research and publication strategy to ensure that they optimise the work they are doing, to look for opportunities to collaborate with colleagues across different disciplines, and to work together on publications and the supervision of postgraduate students.

“She also emphasised the importance of collaborating with people in industry, as they often have a rich source of data that is publishable. She highlighted the importance of being an ethical researcher. The workshop participants benefited from her passion and broad knowledge to start planning collaborations and to reflect on how they can make the work they are already doing work more for them. A group of workshop participants has already started working on a systematic review that they will conduct in collaboration with Prof Comiskey,” said Dr Van den Berg.

Share expertise

Prof Comiskey facilitated online writing interventions for the colleagues of the mentoring programme during COVID-19 lockdown restrictions. She was invited to the campus to share her expertise in quantitative methodology and transdisciplinary work.

Prof Comiskey completed a PhD in Mathematics and coordinates many interdisciplinary research teams, comprising applied mathematicians, statisticians, psychologists, medical doctors, sociologists, anthropologists, nurses, computer scientists, and healthcare employees. She has been selected as one of five international experts nominated by the European Commission to serve on the International Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction.

She has 30 years’ experience of teaching, research, postgraduate supervision, and teaching to specialists and non-specialists in all areas of applied statistics, mathematics, and epidemiology. She is also a seasoned academic leader, having served as Research Director at Trinity College, Dublin for many years.

CHARM-EU is an EU-funded academic programme spanning five European universities to develop, run, and evaluate a new EU-wide model for Universities of the Future. This involves a new transdisciplinary master’s degree that addresses the Sustainable Development Goals (SDG).  

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept